Provided by Tiger Trade Technology Pte. Ltd.

LENSAR Inc

8.80
+0.12001.38%
Volume:74.12K
Turnover:649.74K
Market Cap:108.08M
PE:16.64
High:8.95
Open:8.70
Low:8.54
Close:8.68
52wk High:12.95
52wk Low:4.95
Shares:12.28M
Float Shares:8.85M
Volume Ratio:2.70
T/O Rate:0.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.5288
EPS(LYR):-2.8667
ROE:357.30%
ROA:-18.66%
PB:7.25
PE(LYR):-3.07

Loading ...

Company Profile

Company Name:
LENSAR Inc
Exchange:
NASDAQ
Establishment Date:
2004
Employees:
150
Office Location:
2800 Discovery Drive,Orlando,Florida,United States
Zip Code:
32826
Fax:
- -
Introduction:
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Directors

Name
Position
Nicholas T. Curtis
Chief Executive Officer and Director
Aimee S. Weisner
Independent Director
Elizabeth G. O'Farrell
Independent Director
Gary M. Winer
Independent Director
Richard L. Lindstrom
Independent Director
Thomas B. Ellis
Independent Director
Todd B. Hammer
Independent Director
William J. Link
Chairperson and Independent Director

Shareholders

Name
Position
Nicholas T. Curtis
Chief Executive Officer and Director
Alan B. Connaughton
Chief Operating Officer
Michael A. Rossi
Interim Chief Financial Officer and Secretary